Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Regeneron Pharmaceuticals

14 clinical trials · 14 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Regeneron Pharmaceuticals

RECRUITINGPhase 3NCT06246916

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic...

This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called...

Sponsor: Regeneron PharmaceuticalsEnrolling: 56020 locations
Melanoma
RECRUITINGPhase 3NCT06091254

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With...

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma...

Sponsor: Regeneron PharmaceuticalsEnrolling: 82220 locations
Follicular Lymphoma (FL)
RECRUITINGPhase 1 / Phase 2NCT05828511

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult...

This study is researching an experimental drug called linvoseltamab (called "study drug"). The study is focused on participants with newly diagnosed multiple myeloma (NDMM) who...

Sponsor: Regeneron PharmaceuticalsEnrolling: 14920 locations
Multiple Myeloma
RECRUITINGPhase 1 / Phase 2NCT03761108

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and...

Sponsor: Regeneron PharmaceuticalsEnrolling: 38720 locations
Multiple Myeloma
RECRUITINGPhase 1NCT07216066

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

This study is researching an experimental drug called ALN-SNCA (called "study drug"). The study is focused on people with early Parkinson's disease, a disorder of the nervous...

Sponsor: Regeneron PharmaceuticalsEnrolling: 461 location
Parkinsons Disease
RECRUITINGPhase 2NCT07175428

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too...

Sponsor: Regeneron PharmaceuticalsEnrolling: 120020 locations
Atrial Fibrillation (AF)
RECRUITINGPhase 3NCT07213778

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult...

This study is researching an experimental drug called REGN7508 versus Acetylsalicylic Acid (ASA) (each called "study drug"). The study is focused on adults undergoing elective,...

Sponsor: Regeneron PharmaceuticalsEnrolling: 200010 locations
Symptomatic Venous Thromboembolism (VTE)
RECRUITINGPhase 3NCT07410117

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CAT) in participants....

Sponsor: Regeneron PharmaceuticalsEnrolling: 8605 locations
Cancer-Associated Thrombosis (CAT)
RECRUITINGPhase 1NCT06975787

Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis

This study is researching a particular group of experimental drugs administered for a short period in the treatment of patients with Lupus Nephritis (LN). The main aim of the...

Sponsor: Regeneron PharmaceuticalsEnrolling: 906 locations
Lupus Nephritis (LN)
RECRUITINGPhase 2NCT05519475

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic...

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic dysfunction-associated...

Sponsor: Regeneron PharmaceuticalsEnrolling: 9020 locations
Metabolic Dysfunction-associated Steatohepatitis (MASH)
RECRUITINGPhase 1NCT06836609

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or...

This study is researching an experimental drug called ALN-CIDEB, also referred to as "study drug". The study is focused on participants with metabolic dysfunction-associated...

Sponsor: Regeneron PharmaceuticalsEnrolling: 1322 locations
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis
RECRUITINGPhase 1 / Phase 2NCT06379789

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265)...

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study...

Sponsor: Regeneron PharmaceuticalsEnrolling: 13020 locations
Hemophilia B
RECRUITINGPhase 1 / Phase 2NCT06292780

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain...

This study is researching an experimental drug called linvoseltamab ("study drug"). This study is focused on patients who have AL amyloidosis that has returned or have failed...

Sponsor: Regeneron PharmaceuticalsEnrolling: 22018 locations
Relapsed/Refractory Systemic Light Chain Amyloidosis
RECRUITINGPhase 1 / Phase 2NCT07218770

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

This study is researching an experimental drug called REGN7041 (also referred to as "study drug"). The study is focused on patients who have active inflammation inside of the eye...

Sponsor: Regeneron PharmaceuticalsEnrolling: 724 locations
Active Noninfectious Uveitis Affecting the Posterior Segment